Schedule 13D ownership disclosure

Entrada Therapeutics Inc

Security class unavailable · CUSIP: 29384C108

Event date: 2021-11-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-21-328063
Form type
SC 13D
Filer
Entrada Therapeutics, Inc.
CIK
CIK 1689375
Filed
Nov 12, 2021
Reporting period
Nov 02, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub